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Background. Diabetes mellitus (DM) confers high vascular risk and is a growing national epidemic. We assessed clinical
characteristics and prevalence of diagnosed DM among patients hospitalized with acute myocardial infarction (AMI) in the US
over the last decade. Methods. Data were obtained from all states within the US that contributed to the Nationwide Inpatient
Sample.All patients admitted to hospitalsbetween 1997 and 2006with a primary discharge diagnosisof AMI were included. Time
trends in the proportion of these patients with DM diagnosis were computed. Results. The portion of patients with comorbid
diabetes among AMI hospitalizationsincreased substantially from 18% in 1997 to 30% in 2006 (P<. 0001). Absolute numbers of
AMI hospitalizations in the US decreased 8% (from 729,412 to 672,243), while absolute numbers of AMI hospitalizations with
coexisting DM rose 51% ((131,189 to 198,044), both (P<. 0001). Women with AMI were signiﬁcantly more likely to have DM
than similarly aged men, but these diﬀerences diminished with increasing age. Conclusion. Although overall hospitalizations for
AMI in the US diminished over the last decade, prevalence of diabetes rose substantially. This may have important consequences
for the future societal vascular disease burden.
1.Introduction
Diabetes mellitus is strongly linked to cardiovascular disease
[1]. Prevalence of diabetes in the general US population is
steadily increasing with recent data indicating that 7.7% of
adults have diagnosed diabetes [2]. The growing national
obesity epidemic is expected to result in an even greater
rise in the number of individuals in the United States (US)
diagnosed with type II diabetes mellitus (DM) [3]. However,
there is a paucity of national data on recent patterns and
factorsassociated with diabetesamong personswith incident
cardiovascular events. Incident coronary heart disease, the
principalcauseofdeathamongdiabeticpatients,isespecially
of interest in this regard.
Greater insights into the evolving prevalence of dia-
betes among patients experiencing major vascular events
encountered in routine clinical practice may be of major
public health and economic relevance, especially on a
national level, thereby raising awareness and facilitating
options for broadly enhancing outcomes in such persons
at high vascular risk [4]. The objective of this study was
twofold. First, we aimed to assess recent time trends in the
prevalence of clinically diagnosed diabetes mellitus among
unselected persons hospitalized in the US with an acute
myocardial infarction (AMI). Second, we set out to examine
the independent relationship between sociodemographic,
hospital, and clinical factors and coexisting diabetes mellitus
in patients hospitalized for AMI.
2.Methods
Data were obtained from the Nationwide Inpatient Sam-
ple (NIS), which approximates a stratiﬁed 20% sam-
ple of all non-Federal, short-term, general, and specialty
hospitals serving adults in the United States. Detailed2 Cardiology Research and Practice
Overall
0
5
10
15
20
25
30
35
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
D
M
(
%
)
Figure 1: Overall trends in proportion of patients with a comorbid
diagnosis of diabetes among persons hospitalized with acute
myocardial infarction (AMI) in the United States (US) population
1997–2006: trend P value <.001.
information on the design of the NIS is available at
http://www.hcup-us.ahrq.gov/. From 1997 to 2006, NIS
captured discharge-level information on several million
discharges each year. A unique hospital identiﬁer allows for
linkage of discharge data to an NIS data set with hospital
characteristics.
All patients with a primary diagnosis of AMI were
included whether they were alive or dead at the time of
discharge. This was done by identifying all discharges with
a primary ICD9-CM code of 410.xx (acute myocardial
infarction). For patients with >1 reported code, only the
ﬁrst reported code was included to avoid double counting
patients with multiple reported codes. Total number of AMI
hospitalizations was obtained by summing across codes [5].
We computed the weighted proportion of AMI hospi-
talizations that occurred in persons who had a comorbid
d i a g n o s i so fd i a b e t e sm e l l i t u sa c r o s st h e1 0 - y e a rs t u d y
period. To identify patients with diabetes mellitus, we used
ICD 9-CM codes 250.0–250.9 with a ﬁfth digit 0 or 2
(type II or maturity-onset). As such, codes with a ﬁfth digit
1 or 3 (type I diabetes mellitus) were excluded from the
analyses [6]. This approach has been taken before and for
the purposes of this study was done to include the type
of diabetes known to be strongly connected to obesity [6].
To assess whether there were signiﬁcant linear trends across
time,we includedyearasacontinuousvariable inthelogistic
regression models while adjusting for the NIS survey design.
Univariate logistic regression adjusted for the survey design
variables was used to evaluate sociodemographic, hospital-
level, and clinical predictors one at a time (unadjusted
analysis). To evaluate the independent association of these
factors with presence of comorbid diagnosis, of diabetes
we used multivariable logistic regression modeling after
adjustment for the survey design variables. In the ﬁrst
multivariable model, sociodemographic (age, sex, race) and
hospitalfactors (hospitalregion,AMInumberofhospitaliza-
tions, number of beds, and hospital location/teaching status)
were adjusted for. The second multivariable model adjusted
forthevariablesinmodel1inadditiontoclinicalfactors(i.e.,
comorbid conditions).
In the aforementioned models, the eﬀect of time was
modeled using ﬁve 2-year time intervals from 1997/98
to 2005/06. Since we determined that there was a non-
linear/non-monotone relation between age and the odds
of coexisting diabetes, we used 5 age categories in 10-year
increments (<55, 55–64, 65–74, 75–84, >84) rather than
including age as a continuous variable in the models. In
addition,sincethepreliminary unadjustedanalysesindicated
that the eﬀect of sex diﬀered by age, these age by sex
interaction eﬀects were taken into account by including the
sex ∗ age group interaction terms in the models. The odds
ratios for the eﬀects of sex and age were computed using
linear contrasts under the above models. All data analyses
were conducted using SAS (version 9.1; SAS Institute Inc,
Cary, NC). Statistical hypotheses were tested using P<. 05
as the level of statistical signiﬁcance.
3.Results
The estimated annual absolute numbers of primary acute
MI hospitalizations in the US based on weighted data from
1997 to 2006 are shown in Table 1. Over the 10-year study
period, the actual number of total primary AMI diagnoses in
the United States generally declined, with 57,169 fewer AMIs
(7.8%relativedecrease)in2006comparedto1997,P<. 0001
(Table 1). However, total primary AMI diagnoses among
persons with comorbid diabetes generally rose (Table 1),
with 66,855more AMIs(51%relativerise) in2006compared
to 1997. Hospitalized primary AMI patients with comorbid
DM (Figure 1) constituted 18% in 1997 versus 30% in 2006
(P<. 0001).
Increases in prevalence of DM among AMI patients were
seen in all age groups regardless of sex (Supplementary
Tables 1 and 2 available online at doi:10.4061/2011/145615).
There were signiﬁcant eﬀects by sex, which varied by age
group (Figure 2). In particular, all women aged <84 years
were more likely to have DM than similarly aged men, but
these eﬀects were most pronounced in the youngest age
group (<55 years) and were decreasingly less pronounced in
older age groups. After the age of 84, women and men were
equally likely to have a comorbid DM diagnosis. It should
also be noted, that while the percentage with DM increased
across the study period in both men and women, the rate
of increase appears to be slightly greater in women aged <65
compared to similarly aged men (Figure 2).
Table 2 displays descriptive summary statistics (only
results for years 1997 and 2006 are shown) for patients
hospitalized with primary AMI who had comorbid dia-
betes. These results were broadly comparable across several
variables. Of note, there were also changes of greater than
10 percentage points across the decade in the following
variables: decrease in patients of White race, rise in patients
encountered at urban teaching hospitals; greater prevalence
of hypertension and renal disease. Median duration of
hospitalization lessened by one day (4.4 versus 3.3 days).
Table 3 displays results for the relation between various
factors and the odds of comorbid diagnosis of diabetes
in patients primarily hospitalized with AMI. There was a
signiﬁcant decrease in the odds of having DM at earlier time
intervals (versus later timepoints). Women aged <84 yearsCardiology Research and Practice 3
Table 1: Trends in overall hospital-based primary acute myocardial infarction (AMI) diagnoses in persons with prevalent diabetes mellitus
in the United States: 1997–2006.
Year Weighted total number of AMI Number with DM Percent with DM Standard error
1997 729412 131189 17.99% 0.22%
1998 748368 152885 20.43% 0.20%
1999 726342 161319 22.21% 0.23%
2000 764999 178878 23.38% 0.22%
2001 771910 188468 24.42% 0.22%
2002 762893 196742 25.79% 0.24%
2003 748750 199743 26.68% 0.30%
2004 694297 189719 27.33% 0.32%
2005 661456 189134 28.59% 0.29%
2006 672243 198044 29.46% 0.32%
AMI: acute myocardial infarction; DM: diabetes mellitus.
were more likely to have DM than similarly aged men, but
as previously noted these sex eﬀects were greater in younger
age groups. Men aged >5 5h a da ni n c r e a s ei nt h eo d d so f
having DM compared to men aged <55, but generally there
appeared to be an inverted U shaped relation with age. The
greatest increase in the odds of having DM was observed in
men aged 65–74 (versus <55), whereas men aged >84 were
more similar to men aged <55. Women aged >84 years had a
decrease in the odds of having comorbid DM versus women
aged <55 years, an opposite relationship to that seen in men.
In unadjusted analysis, non-White race was associated
with an increase in odds of having a diagnosis of DM,
while private/other payer types and South region were asso-
ciated with a lower likelihood (Table 3). Medical conditions
associated with greater odds of comorbid DM diagnosis
were congestive heart failure, peripheral vascular disease,
cerebrovascular disease, renal disease, and hypertension
(Table 3). Both multivariable models (Table 3) produced
similar odds ratio estimates and were consistent with the
directions of the unadjusted analysis except for a few
diﬀerences (odds ratios for age >84 versus <55 years in men
and for age 75–84 versus <55 in women changed direction
after adjustment for clinical factors). It should be noted that
after adjustment of other factors, West region was associated
with decreased odds of having DM.
4.Discussion
We found that over the last decade, there was a signiﬁcant
absoluterise of12% in theprevalence ofDM among patients
hospitalized for AMI in the United States. The rise occurred
in the setting of an eight percent decrease in the number of
overall AMI hospitalizations in 2006 (versus 1997) and a 51
percent increase in actual numbers of AMI hospitalizations
with coexisting diabetes in 2006 (versus 1997). Although
it is widely recognized that several countries around the
world are in the midst of a diabetes epidemic [7], and a
major city in the US reported a recent sharp increase in
diabetic patients hospitalized for myocardial infarction [8],
this recent nationwide boost in prevalence among patients
experiencingincidentcoronaryheartdisease,themajorkiller
of individuals with DM [9–11], may be of major public
healthconcernespeciallyif itthreatens thedecliningnational
trend in coronary artery disease events.
Prevalence data for DM among AMI patients across
countries and populations from prior studies conducted in
the 1980s and 1990s ranged from 10 to 24% [9, 12, 13]. In
the generalUSadultpopulation, theprevalenceofdiagnosed
diabetes rose from 5.1% in 1988–1994 to 7.7% in 2005-
2006 [2]. In comparison, our study showed that in the
US, prevalence of DM among AMI patients has increased
to a greater degree than in the general population and
is now four times more frequent in AMI patients. The
precise reasons for the rise in patients hospitalized for AMI
with comorbid DM cannot be readily garnered from this
study based on an administrative dataset. However, based
on prior data [10], recent information [14, 15], and some
speculation, the increasingly higher DM prevalence rates
noted in this nationwide study of AMI patients likely reﬂect
a combination of factors including the higher risk of AMI
in patients with DM, a true rise in the prevalence of DM in
the setting of higher rates of obesity and sedentary lifestyle
[16], better diagnostic techniques, improved documentation
(heightened awareness of diabetes as a coronary risk factor
may have resulted in increased testing for diabetes and more
complete reporting of diabetes), and prolonged survival. A
recent meta-analysis suggests that DM imparts a doubling
of the AMI risk, independent of other vascular risk factors
[17]. The exact contributions of each of these factors may be
hard to determine, but to the extent that there has probably
been a real increase in diabetes among these high-vascular
risk patients, policy makers at all levelsmay want to intensify
eﬀorts to prevent and optimally control diabetes, especially
in the AMI patients we identiﬁed as being at higher odds of
having comorbid DM.
One such group of patients as noted in our study may
be young and middle-aged women. We found a higher
prevalence of DM among women with AMI compared to
their aged-matched male counterparts, a diﬀerence which
lessened with increasing age, but which was most apparent
among AMI patients <55 years. Furthermore, the rate of4 Cardiology Research and Practice
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Figure 2: Overall trends in proportion of patients with a comorbid diagnosis of diabetes by age and sex among persons hospitalized with
acute myocardial infarction (AMI) in the United States (US) population 1997–2006. Incident AMI is on the x-axes.
increase in DM prevalence over the decade appeared to
be slightly greater in women aged <65 years compared to
similarly aged men. A disproportionate burden of coronary
risk factors and comorbidities among younger women
versus their male counterparts has been previously reported
[18], but we are unaware of data explicitly presenting the
magnitude of diﬀerences in DM prevalence among AMI
patients for successive age groups after the age of 55 years.
Such a major diﬀerence in DM prevalence may in part
contribute to the well-known higher rates of in-hospital
mortality seeninwomenversusmenaged<60years [19–21].
It was interesting to note that hypertension and renal
disease diagnoses have also risen substantially over the
decade. Again these increases likely have a multifactorial
basis but conceivably also represent some degree of real
increase.Boththesemedicalconditionsareofcoursestrongly
related to presence of diabetes [22] and indeed were among
the strongest independent predictors of DM diagnosis inCardiology Research and Practice 5
Table 2: Descriptive summarytable for persons withprevalent diabetes mellitus hospitalized primarily with a diagnosisof acute myocardial
infarction in the United States: 1997 versus 2006.
Variable Description
Year 1997 (n = 131,189) Year 2006 (n = 198,043)
Sample
frequency
Weighted
frequency
Weighted
percent SE Sample
frequency
Weighted
frequency
Weighted
percent SE
Sex Male 15283 74592 56.9 0.4 22986 112055 56.6 0.4
Female 11517 56597 43.1 0.4 17574 85988 43.4 0.4
Race
White 17959 87457 66.7 1.7 22021 107674 54.4 2.0
Black 1923 9422 7.2 0.6 3357 16289 8.2 0.6
Other 2189 10228 7.8 0.7 5360 25731 13.0 1.0
Unknown 4729 24081 18.4 1.8 9822 48349 24.4 2.2
Hospital region
North East 6447 32397 24.7 1.5 7979 42120 21.3 1.5
Mid-West 6024 30406 23.2 1.4 8583 43651 22.0 1.4
South 10100 48833 37.2 1.6 17191 80211 40.5 1.7
West 4229 19554 14.9 0.8 6807 32061 16.2 1.0
Location and status
Rural 3951 19958 15.2 0.9 4178 21280 10.7 0.8
Urban nonteaching 13470 64299 49.0 1.6 17238 81061 40.9 1.7
Urban teaching 9379 46932 35.8 1.7 19144 95702 48.3 1.7
Admission source
Emergency 16442 80117 63.1 1.6 25478 124419 63.0 1.6
Another health facility 4909 24157 19.0 1.4 8169 39909 20.2 1.3
Routine 4513 22617 17.8 1.0 6816 33232 16.8 1.1
Comorbid condition
Hypertension 15483 75669 57.7 0.4 30846 150463 76.0 0.4
CVD 1791 8782 6.7 0.2 2626 12824 6.5 0.2
Atrial ﬁbrillation 4238 20695 15.8 0.3 6584 32288 16.3 0.3
Valvular disease 3459 16804 12.8 0.5 5389 26307 13.3 0.4
Congestive heart failure 10808 52957 40.4 0.5 16114 78774 39.8 0.5
PVD 2177 10599 8.1 0.2 4325 21167 10.7 0.4
Dementia 410 2012 1.5 0.1 813 4013 2.0 0.1
CPD 4288 21044 16.0 0.3 8948 43698 22.1 0.4
Mild liver disease 156 732 0.6 0.0 4849 23670 12.0 0.3
Mod/severe liver disease 28 127 0.1 0.0 57 274 0.1 0.0
Renal disease 1696 8322 6.3 0.2 8526 41660 21.0 0.4
Cancer 452 2197 1.7 0.1 881 4335 2.2 0.1
Metastatic cancer 121 561 0.4 0.0 229 1132 0.6 0.0
Median Median
Stay length Days 4.4 3.3
Age Years 69.6 68.1
SE: standard error; CVD: cerebrovascular disease; PVD: peripheral vascular disease; CPD: chronic pulmonary disease; Emergency: patient ﬁrst admitted via
emergency department. Another health facility: patient transferred from nursing home or other ancillary nonacute care health facility. Routine: scheduled
nonmergent admission, typically directly from home, or outpatient program. Cancer: total number of patients with cancer (including metastaticcancers).
our study. Other factors independently linking co-existent
DM with incident AMI in our multivariable analyses were
female sex, non-White race, and comorbid systemic vascular
damage have been noted in other studies [23–26].
Consistent with other studies, there was an overall
decline in the absolute number of AMI hospitalizations
during the study period [27, 28]. In recent study, the annual
AMI hospitalization rate in the fee-for-service population
fell from 1131 per 100 000 beneﬁciary-years in 2002
to 866 in 2007, a relative 23.4% decline. The apparent
reduction in AMI hospitalization may be attributed to
decrease in certain CV risk factors, greater use of car-
diovascular protective medications, and improvements in
coronary revascularization. However, had there not been
such a large temporal increase in the prevalence of DM, the
reduction in AMI hospitalizations during this time period
may have been even more pronounced.
This study has limitations. First, we cannot exclude
possible inaccurate reporting of ICD codes. However, the
ICD-9 diagnosis-coded case deﬁnitions have been consis-
tently well validated in previous studies using the same
or similar hospitalization data [29]. Further, any potential6 Cardiology Research and Practice
Table 3: Factors associated with comorbid diabetes mellitus diagnosis in patients hospitalized primarily for acute myocardial infarction in
the United States between 1997–2006.
Variable Unadjusted Multivariable model no. 1 Multivariable model no. 2
OR Lower Upper P-value OR Lower Upper P-value OR Lower Upper P-value
95% CL 95% CL 95% CL 95% CL 95% CL 95% CL
Year
1997-1998 versus 2005-2006 0.58 0.57 0.60 <.0001 0.57 0.56 0.59 <.0001 0.63 0.61 0.64 <.0001
1999-2000 versus 2005-2006 0.72 0.70 0.74 <.0001 0.72 0.70 0.73 <.0001 0.77 0.75 0.79 <.0001
2001-2002 versus 2005-2006 0.82 0.80 0.84 <.0001 0.81 0.80 0.83 <.0001 0.86 0.84 0.88 <.0001
2003-2004 versus 2005-2006 0.90 0.88 0.93 <.0001 0.89 0.87 0.91 <.0001 0.92 0.89 0.94 <.0001
Demographics
Female versus male in <55 1.54 1.51 1.57 <.0001 1.46 1.43 1.49 <.0001 1.42 1.39 1.45 <.0001
Female versus male in 55–64 1.41 1.38 1.43 <.0001 1.33 1.31 1.36 <.0001 1.28 1.25 1.30 <.0001
Female versus male in 65–74 1.21 1.19 1.23 <.0001 1.18 1.16 1.20 <.0001 1.12 1.10 1.14 <.0001
Female versus male in 75–84 1.06 1.05 1.08 <.0001 1.05 1.03 1.06 <.0001 1.00 0.98 1.02 .8970
Female versus male in >84 0.99 0.96 1.01 .3592 0.98 0.95 1.01 .1160 0.92 0.90 0.95 <.0001
Age 55–64 versus <55 in M 1.62 1.59 1.64 <.0001 1.62 1.60 1.65 <.0001 1.51 1.48 1.53 <.0001
Age 65–74 versus <55 in M 1.94 1.90 1.98 <.0001 1.66 1.62 1.69 <.0001 1.52 1.48 1.55 <.0001
Age 75–84 versus <55 in M 1.76 1.73 1.79 <.0001 1.49 1.45 1.52 <.0001 1.30 1.27 1.33 <.0001
Age >84 versus <55 in M 1.21 1.18 1.24 <.0001 1.02 0.99 1.05 .2905 0.85 0.83 0.88 <.0001
Age 55–64 versus <55 in F 1.48 1.44 1.51 <.0001 1.48 1.44 1.51 <.0001 1.36 1.33 1.39 <.0001
Age 65–74 versus <55 in F 1.53 1.49 1.56 <.0001 1.33 1.30 1.37 <.0001 1.20 1.17 1.23 <.0001
Age 75–84 versus <55 in F 1.22 1.19 1.24 <.0001 1.07 1.04 1.10 <.0001 0.92 0.89 0.94 <.0001
Age >84 versus <55 in F 0.78 0.76 0.80 <.0001 0.68 0.66 0.70 <.0001 0.55 0.54 0.57 <.0001
Race: Black versus White 1.52 1.49 1.55 <.0001 1.50 1.47 1.54 <.0001 1.27 1.24 1.29 <.0001
Race: Other versus White 1.72 1.66 1.78 <.0001 1.75 1.69 1.80 <.0001 1.62 1.58 1.67 <.0001
Race: Unknown versus White 1.00 0.97 1.02 .9365 0.99 0.97 1.02 .5642 0.99 0.97 1.01 .4811
Hospital characteristics
Midwest versus northeast 0.97 0.93 1.00 .0562 1.03 0.99 1.06 .1227 1.03 1.00 1.06 .0608
South versus northeast 0.94 0.91 0.97 .0002 0.93 0.90 0.95 <.0001 0.93 0.90 0.96 <.0001
West versus northeast 0.99 0.95 1.04 .7998 0.96 0.93 0.99 .0228 0.96 0.93 0.99 .0207
Medium versus small bed size∗ 1.00 0.97 1.03 .9390 1.01 0.98 1.04 .5717 1.00 0.98 1.03 .8447
Large versus small bed size∗ 0.97 0.95 1.00 .0698 0.99 0.96 1.02 .6759 0.98 0.95 1.01 .2078
Volume∗∗ quartile: 2 versus 1 1.11 1.06 1.16 <.0001 1.08 1.03 1.13 .0022 1.04 0.99 1.09 .1432
Volume∗∗ quartile: 3 versus 1 1.12 1.06 1.17 <.0001 1.09 1.03 1.15 .0015 1.03 0.98 1.08 .3058
Volume∗∗ quartile: 4 versus 1 1.03 0.98 1.07 .2739 1.02 0.96 1.08 .5026 0.97 0.92 1.03 .3615
Urban nonteaching versus rural 0.96 0.93 0.99 .0078 0.96 0.93 1.00 .0286 0.94 0.91 0.97 .0001
Urban teaching versus rural 0.98 0.95 1.02 .3058 0.97 0.94 1.01 .1820 0.95 0.91 0.98 .0037
Comorbid conditions
Congestive heart failure 1.61 1.59 1.63 <.0001 1.67 1.65 1.69 <.0001
Peripheral vascular disease 1.46 1.43 1.49 <.0001 1.26 1.24 1.28 <.0001
Cerebrovascular disease 1.25 1.23 1.27 <.0001 1.10 1.08 1.12 <.0001
Dementia 0.92 0.89 0.95 <.0001 0.96 0.93 0.99 .0062
Chronic pulmonary disease 0.93 0.92 0.94 <.0001 0.81 0.80 0.82 <.0001
Mild liver disease 0.93 0.89 0.97 .0004 0.90 0.86 0.94 <.0001
Renal disease 1.89 1.85 1.93 <.0001 1.32 1.30 1.35 <.0001
Cancer 0.82 0.80 0.84 <.0001 0.84 0.82 0.87 <.0001
Mod/severe liver disease 1.04 0.94 1.16 .4229 1.03 0.92 1.15 .5980
Metastatic carcinoma 0.72 0.69 0.76 <.0001 0.79 0.75 0.83 <.0001
Valvular disease 0.91 0.90 0.93 <.0001 0.82 0.81 0.83 <.0001
Atrial ﬁbrilation 0.93 0.92 0.94 <.0001 0.87 0.86 0.88 <.0001
Hypertension 1.98 1.96 2.01 <.0001 1.84 1.82 1.86 <.0001
∗Number of short-term acute beds in a hospital. Please see full bed categorization at http://www.hcup-us.ahrq.gov/db/vars/hosp bedsize/nisnote.jsp
∗∗Number of AMI hospitalizations per year for a given hospital; OR: odds ratio; CL: conﬁdence interval; SAH: subarachnoidhemorrhage; ICH: intracerebral
hemorrhage. Multivariable Model no. 1 includes sociodemographic and hospital factors. Multivariable model no. 2 includes sociodemographic, hospital, and
clinical factors. Cancer: total number of patients with cancer (including metastatic cancers). Please note Bonferroni correction was not applied.Cardiology Research and Practice 7
reporting errors in this large database were unlikely to
have been systematic. Second, detailed patient-level data,
such as glucose levels, HbA1c, vascular biomarkers, and
medications were not available for our analysis. Third, since
up to one-fourth of all persons with diabetes may actually
be undiagnosed [30], we may have missed patients with DM
who did not have a premorbid history and were not screened
during their hospitalization. Fourth, we could not count
out hospital AMIs which did not result in hospitalization.
While an increase in out-of-hospital sudden cardiac death
can potentially explain a decline in AMI hospitalizations,
it would not explain the rising prevalence of DM. Finally,
the observed rise in DM prevalence may also have been
impacted by lowering of the fasting plasma glucose range
for diagnosing impaired fasting glucose in 2003 [31], but
between years 1997 and 2006, the rate of increase in DM
prevalence among AMI patients was relatively constant,
suggesting that the change in diagnostic criteria had a
minimal eﬀect on DM rates in this population. In addition,
the substantially higher rise in DM prevalence among AMI
patients versus general population during this time period
suggests that this was probably not a major factor. The
study beneﬁted from its nationwide scope, standardized
methodology, and clinician diagnosed incidence data.
In conclusion, overall risk factor reduction and better
treatment of AMI patients has decreased incidence of AMI
rates, but we observed a recent steep rise in the number
of patients hospitalized for AMI with coexisting DM the
U n i t e dS t a t e s ,ab o o s tt h a ts u g g e s t st h a tt h ep o p u l a t i o n
health burden of diabetic coronary heart disease (CHD)
remains considerableand might be increasing. Futurestudies
are warranted to conﬁrm these results and explore ways to
mitigate this mounting problem, which could exponentially
worsenintheyearstocome,inthefaceofthegrowingobesity
epidemic.
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